|

UDCA Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2/3: 2

Top Sponsors

  • Xijing Hospital of Digestive Diseases2

Indications

  • Primary Biliary Cholangitis2
  • Liver Disease2

Other2 trials

Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
Phase 2/3
Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.